FDA approves Hospira's meropenem for injection, USP (I.V.)
Links shared publicly online about this topic.
- 1,074total visits
FDA approves Hospira's meropenem for injection, USP (I.V.)
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
View full resource at news-medical.net
Tags: Drug, Pharma, Genes, FDA, Antibiotic, Merrem, AstraZeneca, Oncology
Most Recently Shared on June 23, 2010 at 9:30 am By:
Oncology News: FDA approves Hospira's meropenem for injection, USP (I.V.): Hospira, Inc., the world leader in gene... http://bit.ly/9hZfEV
Hospira Receives FDA Approval For Meropenem For Injection, USP (I.V.)
medicalnewstoday.com — “Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V” View full resource at medicalnewstoday.com
Most Recently Shared on June 24, 2010 at 1:07 pm By:
MNT Infect Diseases Health News
Hospira Receives FDA Approval For Meropenem For Injection, USP (I.V.) http://mnt.to/3Fhm #viruses #bacteria
Advertisement
